Due to the pandemic, the conference will be conducted online, as a virtual congress. Physical participation will be considered depending on its status closer to the event.
Dr. Chwalisz is an internationally renowned pre-clinical and clinical researcher, who is recognized by many scientific contributions in the field of women’s health with focus on new therapies for endometriosis, uterine fibroids and uterine bleeding disorders. He is a co-author of 134 peer-reviewed publications, 37 review article and book chapters and numerous abstracts and patent applications. He holds Adjunct Professor positions in the Department of Gynecological Endocrinology and Reproductive Medicine at the Rhine-Westphalia Technical University, Aachen, Germany and the Department of Obstetrics, Gynecology and Reproductive Biology at the Michigan State University, Grand Rapids, MI, USA
During his academic career, Dr. Chwalisz took various leadership positions within research and development at several drug development institutions. He was involved in discovery and clinical development of Selective Progesterone Receptor Modulators (SPRMs), new estrogens, GnRH agonists and oral GnRH antagonists leading to FDA approval of new indications for leuprolide acetate, and the first FDA approval of an oral GnRH antagonist, elagolix, for the management of pain associated with endometriosis.
Dr. Tamar Seckin is an endometriosis specialist and women’s reproductive health advocate. He has been in private practice for over thirty years at Lenox Hill Hospital specializing in advanced laparoscopic procedures, and is recognized for his expertise in complex cases of deep infiltrating endometriosis of the pelvis. He is particularly dedicated to performing fertility preserving surgeries on cases involving the ovaries. He has developed patented surgical techniques, most notably the “Aqua Blue Excision” technique for better visualization of endometriosis lesions. His surgical techniques are based on precision and micro surgery, emphasizing organ and fertility preservation, and adhesion and pain prevention. Dr. Seckin founded the Endometriosis Foundation of America (EFA) in 2008. This is the first research and advocacy foundation of its kind organized by private physicians to raise awareness and emphasize the critical value of surgical excision of endometriosis.
Professor Guo received his Ph.D. from the University of Washington in 1991. He was Assistant and then Associate Research Scientist at University of Michigan, Associate Professor at University of Minnesota, and tenured full Professor at Medical College of Wisconsin. After serving a three-year term Directorship at the Institute of Obstetric and Gynecologic Research, Shanghai Jiao Tong University, he has been Professor at Shanghai OB/GYN Hospital, Fudan University since 2010. He served as Associate Editor for Human Reproduction for two terms and is now an Associate Editor for Human Reproduction Update, Reproductive Sciences, Gynecologic and Obstetric Investigation, and Journal of Endometriosis and Pelvic Pain Disorders. He is a member of the Board of Trustees of the World Endometriosis Society (WES), the Society of Endometriosis and Uterine Disorders (SEUD), and the Asian Society of Endometriosis and Adenomyosis (ASEA), and a member of a WHO Expert Working Group (EWG3A). He is ranked as one of 10 top specialists in endometriosis by ExpertScape . He is a co-founder and a past President of ASEA (2017-2018).
Krina Zondervan is Professor of Reproductive & Genomic Epidemiology at Oxford University and Deputy Head of the Nuffield Department of Women’s and Reproductive Health. She is Co-Director of the Oxford Endometriosis CaRe Centre, with a mission to integrate world-class evidence-based clinical care with an internationally collaborative programme of basic, clinical and translational research into endometriosis and related women’s health conditions. Her research has focused for more than 20 years on understanding the causes of common women’s health conditions through genomic and epidemiological approaches, in order to improve diagnostic and treatment options. She leads a number of global collaborative research initiatives including large-scale studies that have identified genetic variants involved in the development of endometriosis and uterine fibroids; the Global Study of Women’s Health, which has investigated the impact of pelvic pain, subfertility and endometriosis in 10 countries worldwide; and the World Endometriosis Research Foundation EPHect initiative that has standardised data and biological sample collection in endometriosis research globally. She is a member of various charity and grants advisory boards in the field of women’s health, including the World Endometriosis Society and Wellbeing of Women UK, and has published widely on the phenotypic and genetic epidemiology of endometriosis, as well on study design, methods and applications of integrative ‘omics’ analyses in complex disease. She is one of the most highly cited authors in reproductive sciences, and in 2013 was recognised as Outstanding Female Scientist (AcademiaNet, Wellcome Trust nomination).www.wrh.ox.ac.uk/team/krina-zondervan
Khaleque N Khan, MD, PhD, is an Associate Professor and Project Coordinator of the Kyoto Prefectural University of Medicine in Kyoto, Japan. His main research interests are in reproductive endocrinology and immunology, focusing on pathogenesis and physiopathology of endometriosis, adenomyosis and uterine myoma. Dr. Khan previously worked for the WHO medical teams in different South East Asian countries. He is currently an ambassador of the Asian Society for Endometriosis and Adenomyosis. He has established a multinational and multicenter study on endometriosis to improve the fundamental knowledge and health consciousness on endometriosis and to identify high-risk groups among young women. He is a visiting professor of Dhaka Medical University in Bangladesh and Mahidol University in Thailand. Dr. Khan has authored more than 80 original articles, 16 review articles and 12 book chapters. He received the prestigious Royan International Research Award for his outstanding work on endometriosis in 2017.
Professor Bruce Lessey is Professor in the Department of Obstetrics and Gynecology at the Wake Forest School of Medicine and an Attending Physician in its Section on Reproductive Endocrinology and Infertility. He has authored over forty book chapters and published extensively in peer-reviewed journals. He has been the recipient of ASRM Star awards on three occasions and Chaired its endometriosis special interest group. He is a reviewer for prestigious journals including Human Reproduction which he has served also in the capacity of Associate Editor. He has been the recipient of many research grants and his research has focused mainly on endometriosis. One of his main areas of interest is endometrial receptivity in endometriosis.
Professor Tasuku Harada is the Vice President of Tottori University, Japan and a Director of its University Hospital. He is Professor and Chair of Department of Obstetrics and Gynecology Tottori University Faculty of Medicine, Japan.
He has co-authored over 190 articles in peer-review international journals. The most cited paper is “Role of cytokines in endometriosis” published in Fertility Sterility in 2001. He was one of the chief investigators of the drug development on low dose OC and dienogest for endometriosis in Japan. He edited a book “Endometriosis Pathogenesis and Treatment” by Springer 2014.
He is the President of the Japan Society of Endometriosis, a Past President of the Asian Society of Endometriosis and Adenomyosis (2015-2016), Vice President of the Japan Society of Gynaecologic and Obstetric Endoscopy, Managing Director of the Japan Society of Reproductive Medicine and a Board member of the World Endometriosis Society and the Society of Endometriosis and Uterine Disorders
Dr. Asgi Fazleabas is a University Distinguished Professor and MSU Foundation Professor at Michigan State University and Associate Chair of Research in the Department of Obstetrics, Gynecology and Reproductive Biology and Director of the Center for Women's Health Research and Co-Director of the Reproductive and Developmental Sciences Program at Michigan State University.
Dr. Fazleabas has been funded continuously by the National Institutes of Health in the USA since 1986 for studies using the baboon as a model for reproductive biology research. The work in his laboratory has significant translational relevance related to improved pregnancy outcomes in infertile women as well as understanding the etiology and the pathophysiology associated with the development of endometriosis. The baboon model of endometriosis that has been extensively used in his laboratory has led to fundamental discoveries on the mechanisms by which the presence of endometriotic lesions impact uterine receptivity as well as understanding the early cellular and molecular events that contribute to lesion development and the pathophysiology of disease progression.
Amongst his many honors, he was elected as a Fellow of the American Association for the Advancement of Science, and is the recipient of the Research Award, Distinguished Service Award and the Carl G. Hartman award from the Society for the Study of Reproduction.
Kaori Koga, M.D., Ph.D. is an Associate Professor of the Department of Obstetrics and Gynecology, School of Medicine at the University of Tokyo, Japan. Dr. Koga obtained her M.D. from Chiba University in 1996 and her Ph.D. from the University of Tokyo in 2003. She then undertook post-doctoral fellowships in the Uterine Biology Group (Prof. Lois Salamonsen’s laboratory) at Prince Henry’s Institute, Melbourne in 2006, and the Reproductive Immunology Unit (Prof. Gil Mor’s laboratory) in Yale University in 2006–2008. Her research interests include the pathogenesis of infertility, endometriosis, fibroids, preeclampsia and pregnancy complications, and assessment of their medical and surgical treatments including laparoscopic and robotic surgeries, and assisted reproductive technology. Dr. Koga is author or co-author of more than 150 scientific articles published in peer-reviewed international journals, such as Journal of Immunology, Proceedings of the National Academy of Sciences and Nature Reviews Disease Primers.
Dr. Amphan Chalermchockcharoenkit, is Associate Professor in Obstetics and Gynecology, Department of Obsterics and Gynecology, Faculty of Medicine, Siriraj Hospital, Mahidol University. He trained in gynecologic endoscopy at the Department of Obstetrics and Gynecology, Rosenhoehe-Bielefeld Hospital in Germany, obtaining a two year Grant.
In 2001, he was Sub Board certified in Reproductive Medicine by the Thai Royal College of Obstetricians and Gynecologists.
From 2007 onwards he has been working as a Head of Division of Gynecologic Endoscopy of his department and is acting as Director of Thai-German Multidisciplinary Endoscopic Training Center in Thailand, being a key person there. More than 50 Felllows in gynecologic endoscopy have been trained and more than 40 international gynecologic endoscopy workshops have been held in his center.
Since 2015 he has acted as President of The Thai Society of Gynecologic Endoscopists. He hods Board Memberships in the Asian Society of Endometriosis and Adenomyosis and the Asia-Pacific Association of Gynecologic Endoscopy and Minimally Invasive Therapy (APAGE).
Professor Alborzi graduated from Shiraz University of Medical Sciences (SUMS) in 1987 as a specialist in the field of Obstetrics and Gynecology. He then started working at the same University where he was promoted as an Assistant Professor in 2000 and became Professor of Obstetrics and Gynecology in 2005. He is currently Professor and Chairman of Obstetrics and Gynecology and the Head of the Gynecology Endoscopy Division. He is Vice President of Iranian Society of Minimally Invasive Gynecology. Professor Alborzi’s major field of interest is endometriosis and gynecologic laparoscopic surgery. He is the winner of the 11th Razi Research Festival (2005) and the 3rd and 9th Royan International Congress awards (in 2002 and 2008). He introduced many innovative laparoscopic and hysteroscopic procedures to Iran. Moreover, he was the first to use a peritoneal graft for treating cervical aplasia and laparoscopic metroplasty for didelphic uterus in the world. Professor Alborzi has published widely in high ranking journals.
In 2003, Dr. Missmer joined the Harvard University faculty–her alma mater. Author of more than 250 peer-reviewed publications, she is a Reproductive Epidemiologist who served as Fellowship Research Director for the Division of Reproductive Endocrinology and Infertility at Brigham and Women’s Hospital from 2003-2016 and Head of the Reproductive, Perinatal and Pediatric Epidemiology concentration in the Department of Epidemiology, Harvard T.H. Chan School of Public Health from 2012-2016. She currently is Co-Founder and Scientific Director of the Boston Center for Endometriosis, Treasurer of the World Endometriosis Society, ESHRE Endometriosis and Endometrial Disorders Special Interest Group International Advisor, ASRM Endometriosis Special Interest Group Immediate Past Chair, Statistical Advisory Board member for Human Reproduction, and leads WERF EPHect with Krina Zondervan. She became a Global Impact Initiative endowed Professor of Obstetrics, Gynecology and Reproductive Biology at Michigan State University in 2016.
Originally from Sri Lanka, Dharani Hapangama studied medicine and obtained her MD from the University of Edinburgh. She obtained her Fellowship from the Royal College of Obstetricians & Gynaecologists of the UK in 2019. She is currently a Professor in Gynecology and an Honorary Consultant Gynecologist in the Liverpool Women’s Hospital. She is also the Postgraduate Lead (Academic) of the Royal College of Obstetricians & Gynecologists and leads a British Society of Gynecological Endoscopy accredited Endometriosis Specialist center. She is an Associate Editor for the journal Human Reproduction.
She is the Laboratory Head of the Centre for Women’s Health Research the University of Liverpool and leads its Endometrial Research Group of the Department of Women’s Health. Additionally, she is Director of postgraduate studies Department of Women’s Health and Strand convener for MPhil/MRes, University of Liverpool and a member of the Research Advisory Committee, Research for Patient Benefit awards, National Institute of Health Research, UK.
Obtain 15% off on Economy Class and 10% off on Business Class on the base fare when you book with your local SriLankan Airlines office with proof of Registration for ACE2021. Please note that this discount will not apply if you book through a travel agent, but only if you book via the Srilankan Airlines offices. The discount does not apply to taxes and surcharges.
About ASEA – The Asian Society for Endometriosis and Adenomyosis was formed with the intention of promoting research and improving the quality of care received by endometriosis sufferers in the region.
For further details visit the website at www.endometriosis-adenomyosis.asia